141 related articles for article (PubMed ID: 28356977)
1. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.
Higuchi A; Oshima T; Yoshihara K; Sakamaki K; Aoyama T; Suganuma N; Yamamoto N; Sato T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Kunisaki C; Imada T; Masuda M
Oncol Lett; 2017 Feb; 13(2):905-911. PubMed ID: 28356977
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.
Numata K; Oshima T; Sakamaki K; Yoshihara K; Aoyama T; Hayashi T; Yamada T; Sato T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Kunisaki C; Akaike M; Imada T; Masuda M
J Cancer Res Clin Oncol; 2016 Feb; 142(2):415-22. PubMed ID: 26337161
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of
Katayama Y; Oshima T; Sakamaki K; Aoyama T; Sato T; Masudo K; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
In Vivo; 2017; 31(4):565-571. PubMed ID: 28652421
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.
Suzuki Y; Oshima T; Yoshihara K; Sakamaki K; Aoyama T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
Oncol Lett; 2018 May; 15(5):7335-7343. PubMed ID: 29725448
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Tensin 4 Gene Expression in Patients with Gastric Cancer.
Sawazaki S; Oshima T; Sakamaki K; Aoyama T; Sato T; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
In Vivo; 2017; 31(6):1065-1071. PubMed ID: 29102927
[TBL] [Abstract][Full Text] [Related]
6. High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
Maezawa Y; Sakamaki K; Oue N; Kimura Y; Hashimoto I; Hara K; Kano K; Aoyama T; Hiroshima Y; Yamada T; Yamamoto N; Ogata T; Ito H; Cho H; Shiozawa M; Yoshikawa T; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
J Cancer Res Clin Oncol; 2020 Jan; 146(1):75-86. PubMed ID: 31754833
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma.
Guo Y; Yin J; Zha L; Wang Z
Contemp Oncol (Pozn); 2013; 17(2):150-5. PubMed ID: 23788982
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.
Hosoda K; Yamashita K; Ushiku H; Ema A; Moriya H; Mieno H; Washio M; Watanabe M
Oncol Lett; 2018 Feb; 15(2):1853-1860. PubMed ID: 29434882
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma.
Zhai Y; Bai J; Wang S; Gao H; Li M; Li C; Gui S; Zhang Y
J Neurosurg; 2018 Dec; 129(6):1429-1437. PubMed ID: 29303447
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
11. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.
Carvalho I; Milanezi F; Martins A; Reis RM; Schmitt F
Breast Cancer Res; 2005; 7(5):R788-95. PubMed ID: 16168125
[TBL] [Abstract][Full Text] [Related]
13. Relation of INHBA gene expression to outcomes in gastric cancer after curative surgery.
Oshima T; Yoshihara K; Aoyama T; Hasegawa S; Sato T; Yamamoto N; Akito N; Shiozawa M; Yoshikawa T; Numata K; Rino Y; Kunisaki C; Tanaka K; Akaike M; Imada T; Masuda M
Anticancer Res; 2014 May; 34(5):2303-9. PubMed ID: 24778035
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
Ema A; Yamashita K; Ushiku H; Kojo K; Minatani N; Kikuchi M; Mieno H; Moriya H; Hosoda K; Katada N; Kikuchi S; Watanabe M
Cancer Sci; 2014 Dec; 105(12):1591-600. PubMed ID: 25455899
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis.
Cossu-Rocca P; Contini M; Uras MG; Muroni MR; Pili F; Carru C; Bosincu L; Massarelli G; Nogales FF; De Miglio MR
Int J Gynecol Pathol; 2012 Nov; 31(6):570-9. PubMed ID: 23018215
[TBL] [Abstract][Full Text] [Related]
17. Impact of the
Kano K; Sakamaki K; Oue N; Kimura Y; Hashimoto I; Hara K; Maezawa Y; Aoyama T; Fujikawa H; Hiroshima Y; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Cho H; Ito H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
In Vivo; 2020; 34(1):461-467. PubMed ID: 31882514
[TBL] [Abstract][Full Text] [Related]
18. Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
Liu X; Zhang D; Lin E; Chen Y; Li W; Chen Y; Sun X; Zhou Z
BMC Cancer; 2018 Jun; 18(1):699. PubMed ID: 29954375
[TBL] [Abstract][Full Text] [Related]
19. An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer.
Mori M; Shuto K; Kosugi C; Narushima K; Hayashi H; Matsubara H; Koda K
BMC Cancer; 2018 Dec; 18(1):1261. PubMed ID: 30558575
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
